Compound ID | 1022
6-methoxy-1-phenazinol 5,10-dioxide cupric complex
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | ? |
| Institute where first reported: | Hofimann-La Roche Inc |
| Year first mentioned: | 1970 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.